Editorial Commentary

By afschroeder • October 24, 2025

Lerman M, Waterman B, Bergman J. Editorial Commentary. Urol Pract. 2025 Nov;12(6):643. doi: 10.1097/UPJ.0000000000000870. Epub 2025 Oct 23. PMID: 41128384.

Tags: General Internal Medicine, Olive View DoM, Publications

Integrated care in a large public system improves Benign Prostatic Hyperplasia management

Lerman M, Lerner A, Galle J, Wada C, Waterman B, Laviana A, Bergman J. Integrated care in a large public system improves Benign Prostatic Hyperplasia[...]

Health System Affiliation and Care for Dual-Eligible and Non-Dual-Eligible Medicare Beneficiaries

Timbie JW, DeYoreo M, Agniel D, Zhang S, Escarce JJ. Health System Affiliation and Care for Dual-Eligible and Non-Dual-Eligible Medicare Beneficiaries. JAMA Netw Open. 2025[...]

Oliceridine: Examining the clinical evidence, pharmacology, and contested mechanism of action of the first FDA-approved biased opioid agonist

Prommer EE. Oliceridine: Examining the clinical evidence, pharmacology, and contested mechanism of action of the first FDA-approved biased opioid agonist. J Opioid Manag. 2025 Sep-Oct;21(5):377-387.[...]